Drug comparisons
Teplizumab vs Tolazamide
Teplizumab delays T1D in Stage 2 patients unlike Tolazamide, an oral sulfonylurea for T2D. Compare mechanisms, indications, and safety including black box.
No comparison dimensions are available for this page.
Clinical context
This comparison occurs when distinguishing immunotherapy to delay type 1 diabetes from oral sulfonylureas for type 2 diabetes control.
Bottom line
Teplizumab and Tolazamide address unrelated diabetes stages and types so neither is better overall.
All medication comparisons